Analysts have upgraded revenue forecasts for Wave Life Sciences Ltd., expecting a substantial increase in sales pipeline. Despite revenue decline predictions, analysts believe in the company's potential growth compared to industry peers. With no change in the price target, investors are advised to consider future prospects and insider ownership.